Literature DB >> 18936643

Screening colonoscopy and fecal occult blood testing practice patterns: a population-based survey of gastroenterologists.

Federico Rossi1, Julie Ann Sosa, Harry R Aslanian.   

Abstract

OBJECTIVES: Colorectal cancer (CRC) screening guidelines advocate the performance of colonoscopy at 10-year intervals in average-risk patients. Gastroenterologists' acceptance of 10-year intervals between colonoscopies and interim utilization of fecal occult blood testing (FOBT) is largely unknown.
METHODS: A survey instrument of 15 multiple choice items following brief clinical scenarios involving different CRC screening strategies was sent to 72 practicing gastroenterologists in New Haven County, Connecticut to define screening colonoscopy and FOBT utilization practice patterns.
RESULTS: The overall survey response rate was 75%. Eighty percent of respondents recommend a 10-year screening interval in average-risk patients after normal colonoscopy. Fifty-two percent of respondents recommend annual FOBT beginning 1 to 5 years after a normal screening colonoscopy and, if positive, 59% would evaluate further with colonoscopy and/or esophagogastroduodenoscopy. Repeat colonoscopy in a patient with a family history of colon cancer in a first-degree relative at age 64, was recommended in 3 years by 9%, 5 years (67%), and 7 to 10 years (24%). Repeat colonoscopy in an average-risk patient with a suboptimal bowel preparation was recommended at the next available appointment by 17%, 1 year (20%), 3 years (28%), and in 5 to 7 years (35%).
CONCLUSIONS: Most gastroenterologists adhere to colon cancer screening practice guidelines regarding the timing of repeat evaluation in average-risk patients. A range of surveillance intervals was recommended in patients with greater-than-average CRC risk and a suboptimal bowel preparation. A majority of gastroenterologists use interim FOBT and evaluate positive results with additional endoscopic procedures that increase the frequency of surveillance examinations.

Entities:  

Mesh:

Year:  2008        PMID: 18936643     DOI: 10.1097/MCG.0b013e3181599bfc

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  5 in total

1.  Predictors of Poor Adherence of US Gastroenterologists with Colonoscopy Screening and Surveillance Guidelines.

Authors:  Heba Iskandar; Yan Yan; Jill Elwing; Dayna Early; Graham A Colditz; Jean S Wang
Journal:  Dig Dis Sci       Date:  2014-11-04       Impact factor: 3.199

2.  Quality of colonoscopy reporting in community practice.

Authors:  Lena B Palmer; David H Abbott; Natia Hamilton; Dawn Provenzale; Deborah A Fisher
Journal:  Gastrointest Endosc       Date:  2010-06-29       Impact factor: 9.427

3.  Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations.

Authors:  Marion R Nadel; Zahava Berkowitz; Carrie N Klabunde; Robert A Smith; Steven S Coughlin; Mary C White
Journal:  J Gen Intern Med       Date:  2010-04-10       Impact factor: 5.128

4.  Potentially inappropriate screening colonoscopy in Medicare patients: variation by physician and geographic region.

Authors:  Kristin M Sheffield; Yimei Han; Yong-Fang Kuo; Taylor S Riall; James S Goodwin
Journal:  JAMA Intern Med       Date:  2013-04-08       Impact factor: 21.873

5.  Chronic methadone use, poor bowel visualization and failed colonoscopy: a preliminary study.

Authors:  Siddharth Verma; Joshua Fogel; David J Beyda; Brett Bernstein; Vincent Notar-Francesco; Smruti R Mohanty
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.